Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

December 21, 2011
Bioniche Life Sciences Inc. Enters into Two Distribution Agreements for New Animal Health Products

December 13, 2011
Bioniche E. coli Vaccine Granted Import Access to Australia

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.


Investor FAQ

Where are your shares traded?

Bioniche shares trade on the Toronto Stock Exchange and on the Australian Securities Exchange, under the symbol "BNC".

When did Bioniche go public?

Bioniche Inc. became a public company on February 1, 1992. In July, 1999, Bioniche Inc. was amalgamated with Vetrepharm and Renaissance Life Sciences, a holding company, to form Bioniche Life Sciences Inc., operating both animal and human health businesses under one corporate umbrella.

When is the your fiscal year-end?

The Bioniche fiscal year ends June 30th.

Who are your auditors?

The company's auditors are Ernst & Young, LLP of Montréal, Québec.

Who is your legal counsel?

The company's legal counsel is Ogilvy Renault, Toronto, Ontario.

Who is your transfer agent?

CIBC Mellon Trust Company is the Transfer Agent for Bioniche Life Sciences. Inquiries related to change of address, stock transfer, lost certificates etc. should be directed to the Transfer Agent at its principal offices in Toronto.

For information, please contact:

CIBC Mellon Trust Company
P.O. Box 7010
Adelaide Street Postal Station
Toronto, ON, Canada M5C 2W9
Tel: (416) 643-5500 / Toll-free: (800) 387-0825
Fax: (416) 643-5501
E-mail: Inquiries@cibcmellon.com

Who are the members of the Bioniche Board of Directors?

Biographies of the Bioniche senior management team and a listing of the company's Board members can be found here.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy